top of page
Executive Spotlights

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Management affiliates, included contributions from existing shareholders, including 415 Capital and a strategic investor. R3 Vascular intends to allocate the funds to advance the ELITE FDA IDE pivotal trial of its c bioresorbable scaffold, MAGNITUDE®, specifically designed for treating peripheral arterial disease below the knee (BTK PAD).


Read full article here.

Recent Posts

See All

AxoSim appoints Alif Saleh as CEO

New Orleans, LA, June 14, 2024 (Indian Pharma Post) -- AxoSim, a life science firm specializing in lab-grown human brains, has appointed Alif Saleh as its new CEO. Salef, a company builder, brings e

Comments


Life Science Headlines
bottom of page